​Mark Hronec is a biopharma operations and quality leader who partners with emerging and established companies to modernize operations, strengthen execution, and scale from discovery through commercialization. With a foundation in biochemistry and an MBA from Carnegie Mellon, he blends technical mastery with strategic insight to guide organizations through complex transitions, from inspection readiness to enterprise operating model design and execution.

​His experience spans leading global process redesigns, operational transformations, and workforce strategies for clients including Bristol Myers Squibb, Jazz Pharmaceuticals, and Abivax.

​A former scientist turned senior consultant, Mark brings both empathy and precision to his work, helping leaders make decisions that are scientifically sound, operationally feasible, and commercially smart. His commitment is simple yet profound: advancing the systems that bring life-saving medicines to patients faster.